Robert W. Baird Increases Centene (NYSE:CNC) Price Target to $37.00

Centene (NYSE:CNC) had its target price boosted by Robert W. Baird from $36.00 to $37.00 in a report released on Wednesday,MarketScreener reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s target price indicates a potential downside of 4.84% from the company’s current price.

A number of other research analysts also recently issued reports on the company. Mizuho set a $41.00 price target on Centene and gave the company a “neutral” rating in a report on Tuesday, March 10th. Truist Financial raised their price objective on shares of Centene from $47.00 to $49.00 and gave the stock a “buy” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. decreased their target price on shares of Centene from $45.00 to $41.00 and set a “neutral” rating for the company in a research note on Thursday, March 19th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a report on Tuesday, February 10th. Finally, Argus raised shares of Centene to a “hold” rating in a report on Monday, February 9th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $41.88.

Centene Trading Up 3.4%

NYSE CNC opened at $38.88 on Wednesday. Centene has a 1 year low of $25.08 and a 1 year high of $64.15. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. The company has a market capitalization of $19.12 billion, a PE ratio of -2.85, a P/E/G ratio of 0.83 and a beta of 0.59. The company has a fifty day moving average of $38.24 and a 200 day moving average of $38.98.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping the consensus estimate of ($1.22) by $0.03. The company had revenue of $49.73 billion for the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period last year, the firm earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Research analysts forecast that Centene will post 6.86 earnings per share for the current year.

Institutional Investors Weigh In On Centene

Institutional investors have recently added to or reduced their stakes in the stock. Addison Advisors LLC lifted its holdings in Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after purchasing an additional 606 shares in the last quarter. DV Equities LLC purchased a new stake in shares of Centene during the fourth quarter worth about $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in Centene in the 3rd quarter valued at about $27,000. IFC & Insurance Marketing Inc. acquired a new stake in Centene in the 4th quarter worth about $28,000. Finally, SBI Securities Co. Ltd. increased its stake in Centene by 118.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after buying an additional 406 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.